Alayo, Q., Passaro, C., McNulty, J., Hiroshi, N., & Chiocca, E. A. (2017). IMMU-12. THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID AUGMENTS THE SUSCEPTIBILITY OF ONCOLYTIC VIRUS-INFECTED GLIOBLASTOMA CELLS TO PD-1 BLOCKADE THERAPY. Neuro Oncol.
Citação norma ChicagoAlayo, Quazim, Carmela Passaro, John McNulty, Nakashima Hiroshi, and E Antonio Chiocca. "IMMU-12. THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID AUGMENTS THE SUSCEPTIBILITY OF ONCOLYTIC VIRUS-INFECTED GLIOBLASTOMA CELLS TO PD-1 BLOCKADE THERAPY." Neuro Oncol 2017.
Citação norma MLAAlayo, Quazim, et al. "IMMU-12. THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID AUGMENTS THE SUSCEPTIBILITY OF ONCOLYTIC VIRUS-INFECTED GLIOBLASTOMA CELLS TO PD-1 BLOCKADE THERAPY." Neuro Oncol 2017.